Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Affinivax
Affinivax
GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition'
Fierce Biotech
Thu, 10/31/24 - 09:37 am
GSK
Affinivax
vaccines
pneumococcal disease
Biopharma takeout spend ticks up
EP Vantage
Tue, 07/5/22 - 11:02 am
M&A
biotech
Pfizer
Biohaven
Bristol Myers Squibb
Turning Point Therapeutics
GSK
Affinivax
Sierra Oncology
Halozyme Therapeutics
Antares Pharma
Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development
BioSpace
Tue, 06/21/22 - 12:02 pm
Merck
Emergent BioSolutions
Affinivax
Ocugen
vaccines
chikungunya virus
pneumococcal disease
COVID-19
GSK acquiring Affinivax and its next-generation pneumonia vaccine for $2.1 billion upfront
BioPharma Dive
Tue, 05/31/22 - 10:53 am
GSK
M&A
Affinivax
vaccines
pneumococcal disease
Merck's Vaxneuvance lead departs to help develop rival vaccine at Affinivax
Fierce Biotech
Mon, 08/9/21 - 12:12 pm
Merck
vaccines
Affinivax
Vaxneuvance
Pneumococcal Vaccine Snags Breakthrough Therapy Designation
BioSpace
Tue, 07/13/21 - 11:29 pm
Astellas
Affinivax
vaccines
pneumococcal disease
breakthrough therapy
Buoyed by renewed clamor for infectious disease R&D, Affinivax nabs huge $226M funding round
Fierce Biotech
Fri, 01/8/21 - 09:40 am
COVID-19
Affinivax
vaccines
funding
Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies
Pharmaceutical Business Review
Fri, 04/24/20 - 11:03 am
Affinivax
vaccines
MAPS
immunotherapy